Hebei Xingang Pharmaceutical Co., Ltd. Sustainability Profile
Hebei Xingang Pharmaceutical Co., Ltd., commonly referred to as Xingang Pharma, is a prominent player in the pharmaceutical industry, headquartered in Hebei, China. Established in 2001, the company has steadily expanded its operations across various regions, focusing on the development and production of high-quality pharmaceutical products. Xingang Pharma specialises in active pharmaceutical ingredients (APIs) and finished dosage forms, with a commitment to innovation and quality that sets it apart in a competitive market. The company has achieved significant milestones, including certifications from international regulatory bodies, which underscore its dedication to maintaining stringent quality standards. With a robust portfolio of products, including antibiotics and cardiovascular medications, Hebei Xingang Pharmaceutical Co., Ltd. has positioned itself as a trusted supplier in both domestic and international markets, earning recognition for its reliability and excellence in pharmaceutical manufacturing.
DitchCarbon Score
How does Hebei Xingang Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hebei Xingang Pharmaceutical Co., Ltd.'s score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hebei Xingang Pharmaceutical Co., Ltd.'s reported carbon emissions
Hebei Xingang Pharmaceutical Co., Ltd., headquartered in China, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon footprints. However, without specific commitments or data, it is unclear how Hebei Xingang Pharmaceutical is positioning itself in relation to industry standards for sustainability and emissions reduction. As the global focus on climate action intensifies, it will be essential for Hebei Xingang Pharmaceutical to consider developing measurable targets and strategies to enhance its environmental performance and align with best practices in the sector.
How Carbon Intensive is Hebei Xingang Pharmaceutical Co., Ltd.'s Industry?
How Carbon Intensive is Hebei Xingang Pharmaceutical Co., Ltd.'s Location?
Hebei Xingang Pharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hebei Xingang Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
